chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The next day after vaccination, employee awoke with a headache at 07:45 A.M. She took Ibuprofen 800 mg when she got home @ 8:25. Afterwards she laid down because of the headache. Around 2:00 P.M. she took 440 mg of Naproxen. Around 4:00 P.M. she back to bed and slept some more. At 8:15 P.M. she took Ibuprofen 800mg again. She slept all night. The headache has not gone away since it started. She has continued to take Ibuprofen & Naproxen. On 10-3-18 she call Employee Health about the headaches after talking to her supervisor that referred her to Employee Health. I suggested to her to take BENADRYL 50 mg now and then at bedtime. She called this morning 10-4-18 and she still had the headache. While I was filling out the report she took EXCEDRIN 2 tabs (500 mg TYLENOL/500 mg ASA). At times it is worse than others. She has had light sensitivity & has had vomiting x 2 on the second day.
p/vax pt devel a febrile sz & was hosp;6/25/99 pt was still hosp & fever uncontrolled;
Client's mom called stating child left deltoid swollen, red, hot to touch. Instructed bring child to HD. Left arm red, swollen, warm to touch, swollen from shoulder to elbow. Instructed to contact physician. Doctor advised mom to give Tylenol and Benadryl. Client contacted this nurse on 3/31/04 and stared problem resolved and child was well.
Peripheral neuropathy. May have started before vaccination. Did not know what it was and did not pay close attention to when it started.
This case was reported by a consumer and describes the occurrence of visual impairment in a 4 month old male patient who received diphtheria and tetanus toxoids and acellular pertussis absorbed, hepatitis B recombinant and inactivated poliovirus vaccine combined. The reporter is the mother of the patient. A physician or other health care professional has not verified this report. On 2/20/04, the patient received the first dose of Pediarix. On 4/20/04, the patient received the second dose of Pediarix. On 4/20/04, the patient also received and injection of haemophilus influenzae type B conjugate vaccine. At an unspecified time following the second dose of Pediarix, on an unspecified date in May 2004, the patient experienced visual impairment and a delay in global skills such as rolling over. The patient was seen by a neurologist and an ophthalmologist. On 7/17/04, the patient was hospitalized overnight for observation for seizures. The consumer reported that, It was thought that the patient was having seizures, but after various tests and observations, he was not given that diagnosis. On 7/20/04, the patient received the third dose of Pediarix. At the time of initial reporting, the visual impairment and delayed global skills were improved and the seizure-like symptoms were ongoing. Follow up - No additional information available to date.
Swelling in the armpit (4days after the vaccination) Redness around the vaccine injection spot (5 days after being vaccinated) Itchiness, pain and tenderness (next day after being vaccinated)
fussy, vomiting x5, t102.8 ax given APAP along w/cool baths @ home w/no fever change;mom took pt to ER who gave Ibuprofen & the fever went down w/in 20min p/vax;
Case number PHEH2014US024326, is an initial spontaneous report received from a nurse on 02 Dec 2014. This report refers to a 13 year old male patient. Medical history and concomitant medication were not reported. He was vaccinated with FLUVIRIN, (batch number: 14511P, expiry date: Mar 2015) intramuscularly at a dose of 0.5 ml on 05 Nov 2014. Nurse reported that PFS of FLUVIRIN was stored at 49 degree F for 1 hour and 15 minutes. No adverse event was reported following this maladministration (Incorrect storage of drug). No further information was provided.
It started out as a mild scratchy throat, I got text that day that said I was exposed. I went and got tested was positive. I had congestion, cough, and fatigue that lasted 6 weeks. I lost my taste and smell, I had one toe go numb, I got a secondary sinus infection.
- Had a shooting pain down the back of my arm that went to my elbow the first day of the vaccine. Also just normal muscle pain from vaccination site. Both went away after a couple days. Vaccination Clinic informed me to take a low dose aspirin regimen for 30 days due to elevated D-Dimer. - On March 30th, had a small, warm red bump at injection site. My lymph node is the size of a golf ball in my left arm (very squishy though) and pain began shooting down the back of my arm again. I took a picture of the injection site at 2:13 pm. No fever or congestion, and exercised as normal (Running for 28 minutes, walking for 30 minutes). Took a single Tramadol for pain in my arm, seemed to help a little. - March 31st, rash is spreading and itchy. Still warm and still experiencing shooting pain from the back of my arm down into my elbow. as well as the lump in my left armpit. Photographed injection site to show spreading at 12:05 pm. No fever or congestion, and exercised as normal (Boxing for 23 minutes, walking for 30 minutes) Took a single Tramadol for pain and seemed to help a bit.
Right arm pain that continued to worsen as the day went on, progressing across my back and then legs. Felt the worst about exactly 24 hrs after the injection. Felt like a truck ran over me. Took ibuprofen and felt much better the next day.
Received 2nd COVID pfizer vaccine approx 11:15am on 2/18/21. No known reaction from first dose on 1/25/21. Woke up morning of 2/19 and observed extensive petechiae and bloody nose consistent with low platelet count and ITP (immune thrombocytopenic purpura). I was previously diagnosed with ITP and platelet count was 262k confirmed by blood work a couple days before 2nd vaccine. Morning after got blood draw confirming platelets dropped to below 1k. Medical emergency and sent to ER. Admitted and received emergency treatment to increase platelet counts. Ended up requiring splenectomy on 2/22/21. Just discharged from hospital. Multiple medical providers advised me to submit report to VAERS.
"Moderna COVID-19 Vaccine EUA"  Fever, chills, vomiting, nausea, body aches, headache, muscle soreness, injection site pain. Started about an hour after the vaccine administration and lasted until 9am the next day.
High fever; Heart beat constantly over 115/min; Muscle ache; Arm pain; Belly pain; Red dots on skin; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 06May2021 at 18:00 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included dust allergy and allergy to oyster (seafood allergy). Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. On 06May2021 at 23:00, the patient experienced high fever, heart beat constantly over 115/min, muscle ache, arm pain, belly pain and red dots on skin. The events resulted in emergency room/department or urgent care. Therapeutic measures were taken as a result of the events (unspecified). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events high fever, heart beat constantly over 115/min, muscle ache, arm pain, belly pain and red dots on skin were recovering at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
After the shot she felt tired, nauseated, very tired, afraid to go to sleep. When she woke up she has aching pain and itching on and around both shoulders. both shoulders are itching and aching.  she has to use a walker or cane just to walk around.
On Thursday night I started having pain on my upper thigh On Friday it went down the inside of e leg. By Saturday it was sciatica patterned pain that goes down my leg and my back. On Sunday it went down both the inside and outside of my right leg.  Took Tylenol to help me sleep.  I knew I had an appointment on Tuesday. My doctor was unsure if it was related to the vaccine at all because I do have a bad back. It has gotten better. It is at a point where it is noticeable if I take a step wrong, but it is going away. I expect in a week it will be completely gone. I am also doing stretching exercises and using heat and ice.
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a elderly female patient who received SHINGRIX for prophylaxis. On 16th April 2019, the patient received the 1st dose of SHINGRIX. On 16th April 2019, 2 hrs after receiving SHINGRIX, the patient experienced injection site pain, injection site swelling, tiredness and injection site lump. On an unknown date, the outcome of the injection site pain and injection site swelling were not recovered/not resolved and the outcome of the tiredness was recovered/resolved and the outcome of the injection site lump was unknown. It was unknown if the reporter considered the injection site pain, injection site swelling, tiredness and injection site lump to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. The patient received a dose of SHINGRIX on right arm. Two to three hours after vaccination, the patient experienced the arm became sore and swollen at the injection site. A small lump also presented at the site and the patient felt tired. The patient had gone shopping for a few hours after the vaccination and when the patient arrived home, the patient felt more tired than usual. The reporter also stated that, there was other customer at the pharmacy who said they had received SHINGRIX also but had no adverse reactions. The reporter did not consent to follow-up. This case has been linked with case US2019GSK073055, reported by the same reporter.
side effects of the Pfizer COVID vaccine #2 included headache, back pain, diarrhea, chills, diaphoresis and a low-grade fever all noticeable the next day after receiving the vaccine and symptoms lasted 2 days
11/30-12/5/13 cold, fever, cough- 12/3-12/18/13 numbing, tingling - both feet. 12/15/13 ER walk in. Found nothing wrong. 12/17/13 Dr. visit. Diagnosis: Neuropathy. 12/18/13-1/1/14 ER Diagnosis: GBS, Hospitalized and rehab.
surgery scheduled before date of 2nd dose.; sore arm at vaccine site. right arm; This spontaneous case was reported by a consumer and describes the occurrence of PREOPERATIVE CARE (surgery scheduled before date of 2nd dose.) and VACCINATION SITE PAIN (sore arm at vaccine site. right arm) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, the patient experienced VACCINATION SITE PAIN (sore arm at vaccine site. right arm). On an unknown date, the patient experienced PREOPERATIVE CARE (surgery scheduled before date of 2nd dose.). In April 2021, VACCINATION SITE PAIN (sore arm at vaccine site. right arm) had resolved. At the time of the report, PREOPERATIVE CARE (surgery scheduled before date of 2nd dose.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not provided.  Treatment information was not provided.  Patient had 2nd dose and no issues.   Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: Follow-up information received on 28-MAY-2021 contains non-significant information.
Flu Shoot given,  Patient had heart attack within 12 hours,  Stents and angioplasty with good prognosis
pt recvd vax;sl swelling around site of reddened area approx 4"x3" size; itching badly;
Severe Nausea, burning eyes, dizziness, headache, body ache, diarrhea, fatigue. I took my husband to ER on day 5. He was given nausea meds, eye drops and anti- diarrhea meds. I also treated him with an Aleve/Tylenol regimen.
Pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma since January 1989 and Alcohol use (once a week). Concomitant products included OMEPRAZOLE for Heartburn.    On 02-Mar-2021 at 2:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 08-Aug-2020 and the estimated date of delivery was 15-May-2021. On 02-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-ninth week of the pregnancy.  On 02-Mar-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Sep-2020, Pregnancy test: positive (Positive) positive. On 30-Dec-2020, Ultrasound scan: (normal) Patient's ultrasound scanning results were normal.. On 24-Feb-2021, Blood count: (normal) Patient's blood panel results were normal.. On 24-Feb-2021, Blood glucose: (normal) Patient's glucose test results were normal.. On 24-Feb-2021, Ultrasound scan: (normal) Patient's ultrasound scanning results were normal..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication was reported. Patient used to intake alcohol once a week prior to her pregnancy. Patient's was tested positive for pregnancy on 02-Sep-2020 and estimated date of conception was 18-Aug-2020. Patient's prenatal care was established. No complications or acute illnesses and no history of subfertility.
Injection site myalgia; First dose of Shingrix on 31May2019, the second dose on 6Aug2019 and a third dose on 7Mar2020; This case was reported by a pharmacist via call center representative and described the occurrence of injection site muscle pain in a 71-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.    Previously administered products included Shingrix with an associated reaction of injection site pain (1st dose received on 9th March 2020 (please refer case US2020043599 )) and Shingrix (2nd dose received 6th August 2019).   On 7th March 2020, the patient received the 3rd dose of Shingrix. On 7th March 2020, unknown after receiving Shingrix, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered was unknown.  Additional details were received as follows: The patient received 3rd dose, which led to extra dose administered. The reporter consented to follow up. Pharmacist did not provide date of birth of the patient nor expiration date and batch number of the vaccines.   Upon internal review, the following correction were made on 7th April 2020 as follows: On 6th August 2019, the patient received the 2nd dose of Shingrix, less than 9 months after vaccination, experienced injection site muscle pain. On an unknown date, the outcome of the injection site muscle pain were unknown.  It was unknown if the reporter considered the injection site muscle pain to be related to Shingrix.
9x9 cm area of mild redness & induration (R) thigh (KINRIX & Varicella).
No adverse events, but patient was 16 years old and given the Moderna vaccine for his first shot. Should not have been used because under 18.
This non-serious spontaneous case, was initially received from other health professional on 28-Sep-2017, concerning a 70-year-old, elderly male patient. The patient's medical history and concomitant medications were not reported. On 27-Sep-2017, the patient was administered with FLUCELVAX QIV (dose: 0.5 ml, batch number: 185286, expiry date: 30-Apr-2017, route of administration, anatomical location: not reported). The patient received the expired dose of the product, which was considered as expired vaccine used. The reporter assessed the report as non-serious. Non-significant case correction received with IRD 28-Sep-2017: Batch number (185286) was added on the screen and updated expiry date. The narrative was amended accordingly.
itchy arm; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchy arm) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On an unknown date, the patient experienced PRURITUS (itchy arm). At the time of the report, PRURITUS (itchy arm) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information provided.   Reporter did not allow further contact
Extreme inflammation for many months resulting in  tissue damage in the shoulder where the vaccination was given Surgery performed to repair damage and alleviate inflammation.   Pain and limited use is still an issue
drive-through vaccination POD. Patient was in truck In monitoring area feeling a little bit faint after vaccination; then he actually fainted. Nurses called code green for paramedics; patient laid down on a cot for evaluation by paramedics.    Not transported
Client complained of warmth and dizziness after receiving first Pfizer Covid-19 vaccine. Client was sitting in post vaccine waiting area approximately 10 minutes before alerting EMT she was not feeling well. EMT alerted lead PHN  to assist. Client alert and oriented, faced appeared slightly flushed, PHN asked client to lower mask to assess for any swelling or hives. Client denied shortness of breath, chest pain, allergies to vaccines in the past. Client stated room feeling warm. First set of vitals at 1020: blood pressure 124/80, pulse 79, respirations 16. Client was moved to chair near exit door for breeze of air and given water. Client walked with steady gait by herself. Shortly after being closer to open doorway client stated warmth feeling was improving. Per client only allergic to gluten products, only medication she takes is for thyroid and she had taken that this morning. Client asked if she could eat her snack she had in her purse, per client no breakfast this morning. PHN just instructed client to take small sips of water and eat slowly. PHN informed client her wait time would be extended to 30 min observation to make sure symptoms had improved prior to her leaving and client agreed. EMT stayed with client and reassessed vitals after 5 minutes. Blood pressure: 128/80, pulse 75, o2 98, skin color normal, alert and oriented, and client stated symptoms resolving. PHN and EMT reassessed client at 10:40, as client was approaching 30 minute observation. Vitals: blood pressure, 128/78, pulse 78, o2 99. Alert and oriented, client stated prior complaints had resolved. PHN had patient stand up by chair to assess for dizziness and client denied at this time. ER precautions given. EMT  walked client out of building at 10:45, client walked out with steady gait.
Left arm progressive swelling, erythema, poor mobility, worsening over 2 days, extending to elbow
her arm has a little sore; rash at the back of her neck but it's not itchy; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (her arm has a little sore) and RASH (rash at the back of her neck but it's not itchy) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048C21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Aspirin) and Drug allergy (Codeine). Concomitant products included LEVOTHYROXINE SODIUM, AMLODIPINE BESYLATE;BENAZEPRIL and CLONIDINE for an unknown indication.    On 05-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jun-2021, the patient experienced PAIN IN EXTREMITY (her arm has a little sore) and RASH (rash at the back of her neck but it's not itchy). At the time of the report, PAIN IN EXTREMITY (her arm has a little sore) and RASH (rash at the back of her neck but it's not itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter.   Treatment information was not provided.
Patient was administered pfizer covid vaccine at off-site clinic.  approx 10 min post injection, she developed hot flashes, mild sob, and consistent tearing. she did not require any meds on site.  Her BP was 222/125.  EMS was called.  they confirmed BP reading and advised transport.  Patient declined transport.
chills, sweating, tired, injections is swollen, warm and very sore, cough
Significant increase in neuropathy nerve pain in hands snd feet. My neuropathy had been improving and reducing and within 2 days of the Covid Pfizer shot, my nerve pain increased drastically and continued to increase that first week. I now have had to double my Gabapentin dosage to be comfortable from the nerve pain.
second dose side effects were worse; Mild symptoms after the first dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (second dose side effects were worse) and ILLNESS (Mild symptoms after the first dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (second dose side effects were worse) and ILLNESS (Mild symptoms after the first dose). At the time of the report, ADVERSE EVENT (second dose side effects were worse) and ILLNESS (Mild symptoms after the first dose) outcome was unknown. Not Provided          No Concomitant medication No treatment medication  The action taken with the product was not applicable   This case was linked to MOD-2021-116461 (Patient Link).
Within an hour after immunization given patient experiences swollen eyes, nose, and mouth.  No hives reported, reports that she felt itchy.  She took a PO Benadryl, with minimal relief of symptoms.
5 minutes post injection arm became very itchy and a red, swollen warm patch developed (about the size of a half-dollar).  After 20 minutes, initial round of itchiness subsided. For the next 48 hours the injection site was warm, red, swollen (size of half-dollar) with intermittent periods of itchiness. Itchiness is continuing to come and go now (almost 72 hours post injection) but much milder.
Information has been received from a family member concerning an "approximately 4 year old" female patient who on approximately 04-MAY-2011 ("about 12 days ago") was vaccinated subcutaneously with the first 0.5ml dose of PROQUAD (Merck) (lot # not reported). The consumer reported that on 16-MAY-2011 the patient "broke out in a measles or chickenpox like rash on the face and back." The patient sought unspecified medical attention. At the time of reporting, the patient did not recover. Additional information has been requested.
Severe histamine intolerance. Onset of dermatographia and other dermatological concerns. Cannot sleep a full night because of itching skin with no rash or main point of irritation. Only reporting this here because the booster is the only thing I have taken that might have caused this. I don't take ibuprofen or other medications ever (I'm mostly into just letting my body run its course unless there's a pandemic!)